From: Primary lymphoma of the colon: report of two cases and review of literature
Author (year) [Ref.] | Number of cases | Histological type (WHO) | Treatment modality | Survival |
---|---|---|---|---|
Bairey et al. 2006 [3] | 17 | Diffuse large B cell lymphoma | Multimodality, 9 Chemotherapy, 6 Surgery, 2 | Median, 44 months |
Musallam et al. 2010 [26] | 9 | Diffuse large B cell lymphoma, 6 Burkitt lymphoma, 3 | Multimodality, 5 Chemotherapy, 3 Surgery, 1 | Median, 25 months |
Wong and Eu 2006 [11] | 14 | Diffuse large B cell lymphoma | Multimodality, 11 Surgery, 3 | 5-year overall survival, 57% |
Kim et al. 2005 [27] | 95 | B cell, 82.1% T cell, 17.9% | Multimodality, 57 Chemotherapy, 23 Surgery, 15 | 5-year overall survival, 55.2% |
Pandey et al. 2002 [28] | 8 | Large cell, 3 Small cell, 1 Mix large and small, 3 Lymphoblastic, 1 | Surgery with adjuvant therapy in all | 66% 4 years |
Auger et al. 1990 [29] | 22 | Diffuse histiocytic lymphoma | Multimodality, 14 Surgery, 8 | N/A |
Zighelboim and Larson 1994 [30] | 15 | Multimodality, 3 Chemotherapy, 12 | 5-year survival, 27% | |
Gonzalez et al. 2008 [5] | 15 | Multimodality, 12 Surgery, 3 | Median survival, 60 months | |
Doolabh et al. 2000 [2] | 7 | Small non-cleaved, 5 Large cell, 2 | Multimodality, 6 Surgery, 1 | N/A |
Cho et al. 1997 [31] | 23 | Multimodality, 14 Chemotherapy, 4 Surgery, 3 | 10-year survival, 61% | |
Fan et al. 2000 [10] | 37 | High grade, 29 Intermediate and low grade, 8 | Multimodality, 22 Chemotherapy, 2 Surgery, 13 | Median survival, 24 months |
Stanojevic et al. 2008 [14] | 24 | Multimodality, 20 Surgery, 4 | Median survival, 41.9% | |
Busch et al. 1994 [32] | 19 | Multimodality, 14 Chemotherapy, 4 Surgery, 1 | Median survival, 45 months | |
Zinzani et al. 1997 [1] | 32 | High grade, 26 Low grade, 6 | Multimodality, 22 Chemotherapy, 10 | 5-year overall survival, 59% |
Zhou et al. 2011 [25] | 32 | B cell, 22 (DLBCL most common) T cell, 10 | B cell, multimodality (22) T cell, surgery (8) | B cell DFS at 55 months, 88.2% T cell, 3 alive after 23 months |
She et al. 2011 [33] | 10 | B cell, 8 Burkitt, 1 Mantle cell, 1 | Surgery, 7 Chemotherapy, 3 | Median survival Surgery, 17 months Chemotherapy, 13 months |
Zhai et al. 2012 [22] | 46 | B cell origin, 35 T cell, 11 | 5-year survival, 64.2% Progression-free survival, 49.3% | |
Pascual et al. 2013 [34] | 7 | Diffuse large B cell lymphoma, 6 Follicular lymphoma, 1 | Multimodality, 2 Chemotherapy, 2 Surgery, 3 | N/A |
Huang et al. 2013 [35] | 52 | Diffuse large B cell lymphoma, 64.4% | Multimodality, 43 Chemotherapy, 9 | 5-year survival, 71% |
Tevlin et al. 2015 [36] | 11 | Diffuse large B cell lymphoma | Multimodality, 9 Chemotherapy, 1 Radiotherapy alone, 1 | Median event-free survival, 10 months |